• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epilepsy Behav . Status epilepticus and COVID-19: A systematic review

tetano

Editor, Senior Moderator
Epilepsy Behav


. 2021 Mar 17;118:107887.
doi: 10.1016/j.yebeh.2021.107887. Online ahead of print.
Status epilepticus and COVID-19: A systematic review


Fedele Dono[SUP] 1 [/SUP], Bruna Nucera[SUP] 2 [/SUP], Jacopo Lanzone[SUP] 3 [/SUP], Giacomo Evangelista[SUP] 1 [/SUP], Fabrizio Rinaldi[SUP] 2 [/SUP], Rino Speranza[SUP] 1 [/SUP], Serena Troisi[SUP] 4 [/SUP], Lorenzo Tinti[SUP] 5 [/SUP], Mirella Russo[SUP] 1 [/SUP], Martina Di Pietro[SUP] 1 [/SUP], Marco Onofrj[SUP] 1 [/SUP], Laura Bonanni[SUP] 1 [/SUP], Giovanni Assenza[SUP] 6 [/SUP], Catello Vollono[SUP] 7 [/SUP], Francesca Anzellotti[SUP] 8 [/SUP], Francesco Brigo[SUP] 2 [/SUP]



Affiliations

Abstract

Purpose: In March 2020, the World Health Organization declared the SARS-CoV-2 infection-related coronavirus Disease (COVID-19) a pandemic. During the first and second waves of the pandemic spread, there have been several reports of COVID-19-associated neurological manifestations, including acute seizures and status epilepticus (SE). In this systematic review, we summarized the available data on clinical features, diagnosis, and therapy of COVID-19-related SE.
Methods: We performed a systematic search of the literature to identify data on demographics, clinical, neurophysiological, and neuroradiological data of patients with COVID-19-related SE. We used regression models (linear or logistic) with a stepwise forward method to identify features associated with mortality or severity of SE.
Results: Thirty-nine articles were included with a total of 47 cases of SE associated with COVID-19. Age, time between the acute respiratory phase of SARS-CoV-2 infection and SE onset, and hospitalization correlated with a higher SE severity as assessed by quantitative validated scales.
Conclusions: SE can be a neurological manifestation of SARS-CoV-2 infection. Although a possible association between SE and COVID-19 has been reported, the exact mechanisms are still not fully understood. Systemic inflammatory syndrome due to cytokine release could play a role in COVID-19-related SE.

Keywords: Epilepsy; Pandemic; SARS-CoV-2 infection; Status epilepticus.
 
Back
Top Bottom